Q&A on Pharmaceutical Quality System (PQS) – ICH Q10 guideline Part -4

Q&A on Pharmaceutical Quality System (PQS) – ICH Q10 guideline Part -4

Question 1:

What role does leadership play in ensuring the effectiveness of a pharmaceutical quality system?

Answer 1:

Leadership is essential for establishing and maintaining a company-wide commitment to quality and for the performance of the pharmaceutical quality system.

Question 2:

What is the ultimate responsibility of senior management regarding the pharmaceutical quality system?

Answer 2:

Senior management has the ultimate responsibility to ensure an effective pharmaceutical quality system is in place to achieve quality objectives. They are also responsible for defining, communicating, and implementing roles, responsibilities, and authorities throughout the company.

Question 3:

What are some key actions that management should take according to the ICH Q10?

Answer 3:

Management should:

Participate in the design, implementation, monitoring, and maintenance of an effective pharmaceutical quality system.

Demonstrate strong and visible support for the pharmaceutical quality system and ensure its implementation throughout the organization.

Ensure a timely and effective communication and escalation process exists to raise quality issues to the appropriate levels of management.

Define individual and collective roles, responsibilities, authorities, and inter-relationships of all organizational units related to the pharmaceutical quality system.

Conduct management reviews of process performance, product quality, and the pharmaceutical quality system.

Advocate continual improvement.

Commit appropriate resources.

Question 4:

Why is it important for management to conduct management reviews of process performance and product quality?

Answer 4:

It is important for management to conduct management reviews of process performance and product quality to assess the effectiveness of the pharmaceutical quality system and to identify opportunities for improvement.

Question 5:

What is the significance of committing appropriate resources according to the ICH Q10?

Answer 5:

Committing appropriate resources is significant for ensuring the successful implementation and maintenance of the pharmaceutical quality system. This includes allocating sufficient resources such as personnel, equipment, and finances to support quality-related activities and initiatives.

Question 6:

What is the responsibility of senior management regarding the establishment of a quality policy?

Answer 6:

Senior management is responsible for establishing a quality policy that describes the overall intentions and direction of the company related to quality.

Question 7:

What are the key components that the quality policy should include according to the ICH Q10?

Answer 7:

The quality policy should include an expectation to comply with applicable regulatory requirements and should facilitate continual improvement of the pharmaceutical quality system.

Question 8:

Why is it important for the quality policy to be communicated to and understood by personnel at all levels in the company?

Answer 8:

It is important for the quality policy to be communicated to and understood by personnel at all levels in the company to ensure alignment and commitment to quality objectives and principles throughout the organization.

Question 9:

How should the quality policy be periodically reviewed according to the ICH Q10?

Answer 9:

The quality policy should be periodically reviewed for continuing effectiveness to ensure that it remains relevant and aligned with the company’s objectives and quality goals.

Question 10:

What role does senior management play in quality planning according to the ICH Q10?

Answer 10:

Senior management should ensure that the quality objectives needed to implement the quality policy are defined and communicated. They should also ensure that these objectives are supported by all relevant levels of the company and align with the company’s strategies and the quality policy. Additionally, management should provide the appropriate resources and training to achieve the quality objectives.

About Pharmaceutical Guidanace

Ms. Abha Maurya is the Author and founder of pharmaceutical guidance, he is a pharmaceutical Professional from India having more than 18 years of rich experience in pharmaceutical field. During his career, he work in quality assurance department with multinational company’s i.e Zydus Cadila Ltd, Unichem Laboratories Ltd, Indoco remedies Ltd, Panacea Biotec Ltd, Nectar life Science Ltd. During his experience, he face may regulatory Audit i.e. USFDA, MHRA, ANVISA, MCC, TGA, EU –GMP, WHO –Geneva, ISO 9001-2008 and many ROW Regularities Audit i.e.Uganda,Kenya, Tanzania, Zimbabwe. He is currently leading a regulatory pharmaceutical company as a head Quality. You can join him by Email, Facebook, Google+, Twitter and YouTube

Check Also

Q&A ON VALIDATION OF ANALYTICAL PROCEDURES – ICH Q2 GUIDELINE PART -6

Q&A ON VALIDATION OF ANALYTICAL PROCEDURES – ICH Q2 GUIDELINE PART -6 Question 1: How …

Leave a Reply

Your email address will not be published. Required fields are marked *